Mesa Laboratories, Inc. (MLAB)
136.06
-6.17
(-4.34%)
USD |
NASDAQ |
Oct 06, 16:00
135.30
-0.76
(-0.56%)
After-Hours: 06:26
Mesa Laboratories Enterprise Value : 892.02M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 892.02M |
| October 05, 2026 | 926.55M |
| October 02, 2026 | 872.38M |
| October 01, 2026 | 854.19M |
| September 30, 2026 | 857.77M |
| September 29, 2026 | 863.59M |
| September 28, 2026 | 874.84M |
| September 25, 2026 | 880.72M |
| September 24, 2026 | 900.08M |
| September 23, 2026 | 874.95M |
| September 22, 2026 | 884.02M |
| September 21, 2026 | 868.57M |
| September 18, 2026 | 838.75M |
| September 17, 2026 | 842.11M |
| September 16, 2026 | 831.75M |
| September 15, 2026 | 842.16M |
| September 14, 2026 | 810.43M |
| September 11, 2026 | 807.02M |
| September 10, 2026 | 807.24M |
| September 09, 2026 | 824.03M |
| September 08, 2026 | 823.08M |
| September 04, 2026 | 845.69M |
| September 03, 2026 | 849.88M |
| September 02, 2026 | 861.75M |
| September 01, 2026 | 832.76M |
| Date | Value |
|---|---|
| August 31, 2026 | 846.19M |
| August 28, 2026 | 853.02M |
| August 27, 2026 | 850.56M |
| August 26, 2026 | 842.16M |
| August 25, 2026 | 843.28M |
| August 24, 2026 | 826.33M |
| August 21, 2026 | 828.79M |
| August 20, 2026 | 797.40M |
| August 19, 2026 | 800.59M |
| August 18, 2026 | 734.67M |
| August 17, 2026 | 732.99M |
| August 14, 2026 | 724.03M |
| August 13, 2026 | 764.10M |
| August 12, 2026 | 761.86M |
| August 11, 2026 | 753.08M |
| August 10, 2026 | 699.30M |
| August 07, 2026 | 705.06M |
| August 06, 2026 | 695.89M |
| August 05, 2026 | 704.90M |
| August 04, 2026 | 696.62M |
| August 03, 2026 | 715.03M |
| July 31, 2026 | 694.77M |
| July 30, 2026 | 696.06M |
| July 29, 2026 | 688.33M |
| July 28, 2026 | 696.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Lifecore Biomedical, Inc. | 432.47M |
| Repligen Corp. | 9.747B |
| Bio-Techne Corp. | 11.33B |
| Codexis, Inc. | 141.53M |
| MetaStat, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.83M |
| Revenue (Quarterly) | 60.14M |
| Total Expenses (Quarterly) | 57.31M |
| EPS Diluted (Quarterly) | 0.4916 |
| Gross Profit Margin (Quarterly) | 57.87% |
| Profit Margin (Quarterly) | 4.71% |
| Earnings Yield | 0.62% |
| Operating Earnings Yield | 2.95% |
| Normalized Earnings Yield | 0.6212 |